Prominent publications by Benedicte Brichard

KOL Index score: 12086

Allogeneic bone marrow transplantation (BMT) from HLA-identical siblings is an accepted treatment for both thalassemia and sickle cell disease (SCD). However, it is associated with decided risk of both transplant-related mortality (TRM) and chronic graft-versus-host disease (GVHD). We analyzed 44 patients (median age, 5 years; range, 1-20 years) given an allogeneic related cord blood transplant for either thalassemia (n = 33) or SCD (n = 11). Thirty children were given cyclosporin A ...

Known for Blood Transplantation |  Cell Disease |  Patients Thalassemia |  Survival Graft |  Gvhd Prophylaxis

Key People For Sickle Cell Disease

Top KOLs in the world
Elliott P Vichinsky
sickle cell disease iron overload pulmonary hypertension
Martin H Steinberg
sickle cell anemia fetal hemoglobin cell disease
Samir K Ballas
sickle cell disease iron overload cell anemia
Oswaldo L Castro
sickle cell disease pulmonary hypertension iron overload
Russell E Ware
sickle cell anemia children sca hydroxyurea therapy
Mark T Gladwin
sickle cell disease pulmonary hypertension nitric oxide

Benedicte Brichard:Expert Impact

Concepts for whichBenedicte Brichardhas direct influence:Sickle cell disease,  Blood transplantation,  Patients thalassemia,  Cell disease,  Survival graft,  Gvhd prophylaxis,  Host disease,  Donor engraftment.

Benedicte Brichard:KOL impact

Concepts related to the work of other authors for whichfor which Benedicte Brichard has influence:Cord blood,  Sickle cell disease,  Cell transplantation,  Hematopoietic stem,  Thalassemia major,  Gvhd prophylaxis,  Hla matching.



Is this your profile? manage_accounts Claim your profile content_copy Copy URL code Embed Link to your profile

FREE Custom List